Search

Memorial Sloan Kettering has convened a COVID-19 Operating Room Executive Committee to scrutinize all surgical cases and determine whether they were truly essential and to review needs, resources, and ICU availability.

… Monday, May 11, 2020 The COVID-19 pandemic has stressed healthcare systems globally and is presenting particular challenges to cancer surgeons and cancer surgery programs. As New York City quickly became the epicenter of the pandemic in the United States, Memorial Sloan Kettering convened an Operating

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

… Wednesday, February 21, 2018 Summary In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to new targeted therapies. Last month, the US Food and Drug Administration

Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite early-stage drug discovery of innovative new therapies. Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. from the realm of small molecule discovery into the new research area of antibody drug discovery. All three institutions will benefit from Tri-I TDI’s expansion.

… Thursday, June 16, 2016 Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite

Learn about a new initiative led by MSK pediatric hematologic oncologist Tanya Trippett that aims to improve cancer care and research in Ghana.

… Friday, February 28, 2020 Summary A new initiative led by Memorial Sloan Kettering pediatric hematologic oncologist Tanya Trippett aims to improve cancer care and research in the West African nation. Cancer doesn’t discriminate. Few people are more keenly aware of this fact than Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSK) announces the return of NYC for MSK to celebrate MSK’s 141st anniversary.

… Tuesday, June 3, 2025 Memorial Sloan Kettering Cancer Center (MSK) announces the return of  NYC for MSK  to celebrate MSK’s 141st anniversary. For one day, New York City’s most notable brands in fashion, food, toys, and sports will come together to support MSK’s mission of ending cancer for life. On

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

… Thursday, April 9, 2015 Summary Most cancers treated with targeted therapy ultimately become resistant to treatment, stop shrinking, and eventually progress. New research led by investigators at Memorial Sloan Kettering shows how melanoma and lung cancer cells that initially respond to targeted therapies

Chemotherapy is among the most commonly prescribed, and commonly misunderstood, cancer treatments. It’s time to revise what you thought you knew.

… Tuesday, August 30, 2016 Summary Chemotherapy drugs have evolved considerably over the years. Now, we can treat patients with little to no interference in their everyday lives. We have made great strides in treating cancer with chemotherapy drugs, yet myths about these medications still remain. Donna

Discover how cyclist Stacia Smart turned her grief into purpose after her boyfriend died of a brain tumor.

… Friday, January 1, 2021 Bright, athletic, gregarious, and kind, Owen Strong was enjoying a quintessential life in Manhattan. Living with college friends from Tufts, he was working in the family real estate business and recording songs with his band, the Evening Fools. Then, in February 2018, at age 28

It’s not every day that scientists discover a new part of the cell. Two biologists from the Sloan Kettering Institute just did.

… Thursday, November 15, 2018 Summary Scientists at the Sloan Kettering Institute have discovered a new organelle. The finding challenges longstanding ideas about cell structure. Many people probably remember cell organelles from high school biology. Mitochondria are a cell’s “energy factories.” The nucleus

… Thursday, March 12, 2009 Student Research Eric Alonzo Eric Alonzo Recent publications from our students. Eric Alonzo Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim HJ, Im JS, Pandolfi PP, Sant’Angelo DB. The BTB-zinc finger transcriptional regulator PLZF controls the